{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:07:05Z","timestamp":1790665625584,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s10495-012-0717-2","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T14:13:24Z","timestamp":1333030404000},"page":"989-997","source":"Crossref","is-referenced-by-count":124,"title":["Thioridazine induces apoptosis by targeting the PI3K\/Akt\/mTOR pathway in cervical and endometrial cancer cells"],"prefix":"10.1007","volume":"17","author":[{"given":"Sokbom","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Myung","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boh-Ram","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Sun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Trink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jung","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Bae","family":"Rho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,30]]},"reference":[{"key":"717_CR1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0885-3924(98)00014-1","volume":"15","author":"J Cowap","year":"1998","unstructured":"Cowap J, Hardy J (1998) Thioridazine in the management of cancer-related sweating. J Pain Symptom Manag 15:266","journal-title":"J Pain Symptom Manag"},{"key":"717_CR2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0889-8588(02)00018-7","volume":"16","author":"DS Zhukovsky","year":"2002","unstructured":"Zhukovsky DS (2002) Fever and sweats in the patient with advanced cancer. Hematol Oncol Clin North Am 16:579\u2013588","journal-title":"Hematol Oncol Clin North Am"},{"key":"717_CR3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1191\/0269216302pm570oa","volume":"16","author":"KL Ly","year":"2002","unstructured":"Ly KL, Chidgey J, Addington-Hall J et al (2002) Depression in palliative care: a systematic review. Part 2 treatment. Palliat Med 16:279\u2013284","journal-title":"Palliat Med"},{"key":"717_CR4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/bjc.1984.207","volume":"50","author":"A Ramu","year":"1984","unstructured":"Ramu A, Spanier R, Rahamimoff H et al (1984) Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells. Br J Cancer 50:501\u2013507","journal-title":"Br J Cancer"},{"key":"717_CR5","first-page":"839","volume":"76","author":"S Akiyama","year":"1986","unstructured":"Akiyama S, Shiraishi N, Kuratomi Y et al (1986) Circumvention of multiple-drug resistance in human cancer cells by thioridazine, trifluoperazine, and chlorpromazine. J Natl Cancer Inst 76:839\u2013844","journal-title":"J Natl Cancer Inst"},{"key":"717_CR6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/BF00217059","volume":"91","author":"WH Munyon","year":"1987","unstructured":"Munyon WH, Salo R, Briones DF (1987) Cytotoxic effects of neuroleptic drugs. Psychopharmacology 91:182\u2013188","journal-title":"Psychopharmacology"},{"key":"717_CR7","first-page":"5399","volume":"50","author":"JS Strobl","year":"1990","unstructured":"Strobl JS, Kirkwood KL, Lantz TK (1990) Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine. Cancer Res 50:5399\u20135405","journal-title":"Cancer Res"},{"key":"717_CR8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0014-2999(96)00526-2","volume":"313","author":"L Glass-Marmor","year":"1996","unstructured":"Glass-Marmor L, Morgenstern H, Beitner R (1996) Calmodulin antagonists decrease glucose 1,6-bisphosphate, fructose 1,6-bisphosphate, ATP and viability of melanoma cells. Eur J Pharmacol 313:265\u2013271","journal-title":"Eur J Pharmacol"},{"key":"717_CR9","first-page":"3190","volume":"49","author":"M Kamiwatari","year":"1989","unstructured":"Kamiwatari M, Nagata Y, Kikuchi H et al (1989) Correlation between reversing of multidrug resistance and inhibiting of [3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell line. Cancer Res 49:3190\u20133195","journal-title":"Cancer Res"},{"key":"717_CR10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/mutage\/14.2.243","volume":"14","author":"AA Pantazaki","year":"1999","unstructured":"Pantazaki AA, Lialiaris TS (1999) A combined biochemical and cytogenetic study of thioridazine-induced damage to nucleic acids. Mutagenesis 14:243\u2013248","journal-title":"Mutagenesis"},{"key":"717_CR11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/sj.bjp.0704672","volume":"136","author":"T Rodrigues","year":"2002","unstructured":"Rodrigues T, Santos AC, Pigoso AA et al (2002) Thioridazine interacts with the membrane of mitochondria acquiring antioxidant activity toward apoptosis\u2014potentially implicated mechanisms. Br J Pharmacol 136:136\u2013142","journal-title":"Br J Pharmacol"},{"key":"717_CR12","first-page":"247","volume":"57","author":"A Basta-Kaim","year":"2006","unstructured":"Basta-Kaim A, Budziszewska B, Jag\u0142a G et al (2006) Inhibitory effect of antipsychotic drugs on the Con A- and LPS-induced proliferative activity of mouse splenocytes: a possible mechanism of action. J Physiol Pharmacol 57:247\u2013264","journal-title":"J Physiol Pharmacol"},{"key":"717_CR13","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D et al (2006) The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313:1929\u20131935","journal-title":"Science"},{"key":"717_CR14","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/sj.onc.1207115","volume":"22","author":"TF Franke","year":"2003","unstructured":"Franke TF, Hornik CP, Segev L et al (2003) PI3K\/Akt and apoptosis: size matters. Oncogene 22:8983\u20138998","journal-title":"Oncogene"},{"key":"717_CR15","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.96.8.4240","volume":"96","author":"LC Cantley","year":"1999","unstructured":"Cantley LC, Neel BG (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase\/AKT pathway. Proc Natl Acad Sci USA 96:4240\u20134245","journal-title":"Proc Natl Acad Sci USA"},{"key":"717_CR16","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1158\/0008-5472.CAN-05-0425","volume":"66","author":"X Yang","year":"2006","unstructured":"Yang X, Fraser M, Moll UM et al (2006) Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway. Cancer Res 66:3126\u20133136","journal-title":"Cancer Res"},{"key":"717_CR17","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1038\/sj.onc.1207721","volume":"23","author":"DA Altomare","year":"2004","unstructured":"Altomare DA, Wang HQ, Skele KL et al (2004) AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene 23:5853\u20135857","journal-title":"Oncogene"},{"key":"717_CR18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.275.5300.665","volume":"275","author":"TF Franke","year":"1997","unstructured":"Franke TF, Kaplan DR, Cantley LC et al (1997) Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275:665\u2013668","journal-title":"Science"},{"key":"717_CR19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/excr.1999.4701","volume":"253","author":"B Vanhaesebroeck","year":"1999","unstructured":"Vanhaesebroeck B, Waterfield MD (1999) Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253:239\u2013254","journal-title":"Exp Cell Res"},{"key":"717_CR20","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1038\/sj.onc.1203598","volume":"19","author":"ZQ Yuan","year":"2000","unstructured":"Yuan ZQ, Sun N, Feldman RI et al (2000) Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase\/Akt pathway in human ovarian cancer. Oncogene 19:2324\u20132330","journal-title":"Oncogene"},{"key":"717_CR21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc1362","volume":"4","author":"MA Bjornsti","year":"2004","unstructured":"Bjornsti MA, Houghton PJ (2004) The mTOR pathways: a target for cancer therapy. Nat Rev Cancer 4:335\u2013348","journal-title":"Nat Rev Cancer"},{"key":"717_CR22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ccr.2004.05.027","volume":"5","author":"MA Bjornsti","year":"2004","unstructured":"Bjornsti MA, Houghton PJ (2004) Lost in translation: dysregulation of cap-dependent translation and cancer. Cancer Cell 5:519\u2013523","journal-title":"Cancer Cell"},{"key":"717_CR23","doi-asserted-by":"crossref","first-page":"9382","DOI":"10.1073\/pnas.89.20.9382","volume":"89","author":"J Zhang","year":"1992","unstructured":"Zhang J, Snyder SH (1992) Nitric oxide stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci USA 89:9382\u20139385","journal-title":"Proc Natl Acad Sci USA"},{"key":"717_CR24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0076-6879(97)80117-6","volume":"280","author":"J Zhang","year":"1997","unstructured":"Zhang J (1997) Use of biotinylated NAD to label and purify ADP-ribosylated proteins. Methods Enzymol 280:255\u2013265","journal-title":"Methods Enzymol"},{"key":"717_CR25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/81715","volume":"26","author":"DA Fruman","year":"2000","unstructured":"Fruman DA, Mauvais-Jarvis F, Pollard DA (2000) Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha. Nat Genet 26:379\u2013382","journal-title":"Nat Genet"},{"key":"717_CR26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2010.10.003","volume":"120","author":"SB Rho","year":"2011","unstructured":"Rho SB, Kim BR, Kang S (2011) A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3\u2032-kinase (PI3K)\/AKT pathway in ovarian cancer cells. Gynecol Oncol 120:121\u2013127","journal-title":"Gynecol Oncol"},{"key":"717_CR27","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/sj.onc.1209990","volume":"26","author":"X Wan","year":"2007","unstructured":"Wan X, Harkavy B, Shen N et al (2007) Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 26:1932\u20131940","journal-title":"Oncogene"},{"key":"717_CR28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/excr.1999.4690","volume":"253","author":"ES Kandel","year":"1999","unstructured":"Kandel ES, Hay N (1999) The regulation and activities of the multifunctional serine\/threonine kinase Akt\/PKB. Exp Cell Res 253:210\u2013229","journal-title":"Exp Cell Res"},{"key":"717_CR29","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/carcin\/bgm052","volume":"28","author":"C Blanco-Aparicio","year":"2007","unstructured":"Blanco-Aparicio C, Renner O, Leal JF et al (2007) PTEN, more than the AKT pathway. Carcinogenesis 28:1379\u20131386","journal-title":"Carcinogenesis"},{"key":"717_CR30","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.1158\/1078-0432.CCR-05-0206","volume":"11","author":"L Hu","year":"2005","unstructured":"Hu L, Hofmann J, Jaffe RB (2005) Phosphatidylinositol 3-kinase mediates angiogenesis and vascular permeability associated with ovarian carcinoma. Clin Cancer Res 11:8208\u20138212","journal-title":"Clin Cancer Res"},{"key":"717_CR31","first-page":"880","volume":"6","author":"L Hu","year":"2000","unstructured":"Hu L, Zaloudek C, Mills GB et al (2000) In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002). Clin Cancer Res 6:880\u2013886","journal-title":"Clin Cancer Res"},{"key":"717_CR32","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1158\/1078-0432.CCR-06-2770","volume":"13","author":"S Mabuchi","year":"2007","unstructured":"Mabuchi S, Altomare DA, Cheung M et al (2007) RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model. Clin Cancer Res 13:4261\u20134270","journal-title":"Clin Cancer Res"},{"key":"717_CR33","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1158\/1078-0432.CCR-09-0365","volume":"15","author":"S Mabuchi","year":"2009","unstructured":"Mabuchi S, Kawase C, Altomare DA et al (2009) mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary. Clin Cancer Res 15:5404\u20135413","journal-title":"Clin Cancer Res"},{"key":"717_CR34","first-page":"1982","volume":"55","author":"Y Shi","year":"1995","unstructured":"Shi Y, Frankel A, Radvanyi LG et al (1995) Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro. Cancer Res 55:1982\u20131988","journal-title":"Cancer Res"},{"key":"717_CR35","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1101\/gad.995802","volume":"16","author":"DC Fingar","year":"2002","unstructured":"Fingar DC, Salama S, Tsou C et al (2002) Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1\/eIF4E. Genes Dev 16:1472\u20131487","journal-title":"Genes Dev"},{"key":"717_CR36","first-page":"107","volume":"15","author":"I Gil-Ad","year":"2006","unstructured":"Gil-Ad I, Shtaif B, Levkovitz Y et al (2006) Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth. Oncol Rep 15:107\u2013112","journal-title":"Oncol Rep"},{"key":"717_CR37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(88)90202-4","volume":"2","author":"A Hercbergs","year":"1988","unstructured":"Hercbergs A (1988) Thioridazine: a radiation enhancer in advanced cervical cancer? Lancet 2:737","journal-title":"Lancet"},{"key":"717_CR38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF00613621","volume":"23","author":"R Axelsson","year":"1982","unstructured":"Axelsson R, Martensson E, Alling C (1982) Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism. Eur J Clin Pharmacol 23:359\u2013363","journal-title":"Eur J Clin Pharmacol"},{"key":"717_CR39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0140-6736(72)92955-8","volume":"2","author":"LK Csatary","year":"1972","unstructured":"Csatary LK (1972) Chlorpromazines and cancer. Lancet 2:338\u2013339","journal-title":"Lancet"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10495-012-0717-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T16:18:17Z","timestamp":1497975497000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-012-0717-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,30]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["717"],"URL":"https:\/\/doi.org\/10.1007\/s10495-012-0717-2","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,30]]}}}